Students from the Stony Brook Medicine Healthy Libraries Program will soon be visiting Com-sewogue Public Library for two special HeLP events designed for community members of all ages.
The students, who are currently training in the fields of social work, public health, and nutrition, will be available outside on the Library grounds on both April 14 and May 12, from 10 a.m. until 1 p.m. to provide information and answer questions on a wide variety of vital topics, including how to find community resources, reliable health information, fill out paperwork for social services and find housing.
During the first hour of each HeLP event, the Long Island Cares Mobile Food Pantry Van will be on-site giving out free food, while supplies last. All are welcome and no ID is required.
The Stony Brook Medicine Healthy Libraries Program is a partnership between the Public Libraries of Suffolk County, a unique group of healthcare professionals, and graduate student interns working together to provide access to both in-person and virtual healthcare-related resources for public library patrons throughout Suffolk County.
Comsewogue Public Library is located at 170 Terryvillle Road, Port Jefferson Station. In case of in-clement weather, the events will be moved inside. For questions, call the Library at 631-928-1212, option 3.
Courtesy of Jennifer Quirk-Senyk, adult services librarian at Comsewogue Public Library
Teresa Habacker, MD, FAAOS, FASSH and her practice, East End Hand Center, have joined Stony Brook Medicine Community Medical Group, Stony Brook Medicine’s expanding network of community practices.
“We are happy to welcome Dr. Habacker to a more inclusive role in Stony Brook Medicine. For more than five years, Dr. Habacker has served the Stony Brook Medicine community on the hand surgery/trauma team and the Hand Surgery Fellowship Training Program,” said Lawrence Hurst, MD, Professor and Chair of Orthopaedics, Chief of Hand Surgery at Stony Brook Medicine. “In our new relationship, we look forward to expanding her role in these areas, as well as the Center for Musculoskeletal Health, providing world-class care to patients on the East End.”
Dr. Habacker is a board-certified orthopedic surgeon with an additional certification in hand surgery. She provides comprehensive orthopedic care in Mattituck, Port Jefferson, Southampton and Wading River.
“I have had the pleasure of working with Dr. Hurst and the hand surgery team,” said Dr. Habacker. “I am pleased to be a part of the Center for Musculoskeletal Health and I look forward to working with the local physicians and ancillary teams as I continue to serve the communities on the East End of Long Island.”
Dr. Habacker completed her medical degree at the Medical College of Virginia in Richmond, VA. She completed her surgical residency at SUNY Downstate Medical School in Brooklyn, NY and her orthopedic surgical residencies at Louisiana State University in New Orleans, LA and Long Island Jewish Medical Center in New Hyde Park, NY. Dr. Habacker then went on to complete a hand surgery fellowship at Thomas Jefferson University in Philadelphia, PA. She is an Assistant Clinical Professor and has admitting privileges at Stony Brook University Hospital, Catholic Health Services and Northwell Health hospitals in Suffolk County.
East End Hand Center is accepting new patients. Office hours are Monday through Friday. To make an appointment, call 631-473-4263.
About Stony Brook Medicine
Stony Brook Medicine integrates and elevates all of Stony Brook University’s health-related initiatives: education, research and patient care. It includes five Health Sciences schools — Dental Medicine, Health Technology and Management, Medicine, Nursing and Social Welfare — as well as Stony Brook University Hospital, Stony Brook Southampton Hospital, Stony Brook Eastern Long Island Hospital, Stony Brook Children’s Hospital and more than 230 community-based healthcare settings throughout Suffolk County. To learn more, visit www.stonybrookmedicine.edu
About Stony Brook Medicine Community Medical Group
Stony Brook Medicine Community Medical Group, an arm of Stony Brook Medicine, includes over 35 community practices with over 50 locations across Long Island, from Farmingdale to Greenport. We offer exceptional care by more than 100 providers in 18 specialties committed to enhancing medical care coordination in the community. To learn more, visit sbcommunitymedical.org
Online education has been part of the School of Nursing since 1994. Photo from Stony Brook Medicine
For the second year in a row, the Stony Brook University School of Nursing’s Online Master’s Program was ranked in the top 10 schools nationwide by the U.S. News and World Report in its 2021 College Rankings.
The program has remained in the top 20 for online graduate nursing programs in all but one of the past eight years. In 2020, the program was ranked 7th and in 2021 ranked 9th in the list of Best Online Master’s in Nursing Programs. Officials at the school say the change in ranking from last year to this year may be due to the slight decline in faculty numbers because additional hiring remained difficult due to the pandemic.
The School of Nursing began offering online education in 1994. It started with a Midwifery program and developed into an array of other nurse practitioner education programs. This led to more than 25 years of developing and refining innovative online programs to provide a firm foundation of new online learning applications for nurses and future nurses.
“Our longstanding experience became critical to continued success with online learning this past year in responding to the health care needs and educational changes during the pandemic,” says Annette Wysocki, PhD, RN, FAAN, Dean of the School of Nursing. “Our constant attention to content and presentation methods provides students with visual, graphic and other ways to access content, and this even includes active engagement with simulated clinical experiences within online educational platforms.”
According to U.S. News, online graduate nursing data used as methodology to calculate the rankings included five areas of data: engagement (30 percent); expert opinion (20 percent); faculty credentialing and training (20 percent); services and technologies (20 percent); and student excellence (10 percent).
For more details about the methodology, see this link.
In the effort to save lives and find another safe and effective COVID-19 vaccine, Stony Brook Medicine is participating in a Phase 3 clinical trial to test the safety and effectiveness of a Novavax investigational vaccine for SARS-CoV-2, the novel coronavirus that causes COVID-19.
Stony Brook is the only Long Island site participating in this clinical trial, and one of two in New York State to be selected for the trial.
The study began on Dec. 27 and is led locally by principal investigator Benjamin J. Luft, MD, Edmund D. Pellegrino Professor of Medicine at the Renaissance School of Medicine at Stony Brook University, and Adult Infectious Diseases Expert; and Sub-Investigator Sharon Nachman, MD, Professor of Pediatrics and Associate Dean for Research at the Renaissance School of Medicine. The randomized, blinded placebo-controlled phase III clinical trial will assess the immunity and safety of the Novavax vaccine candidate, as well as its ability to reduce disease in those who contract the virus.
Sponsored by the National Institutes of Health’s (NIH) COVID-19 Prevention Network, the study will recruit up to 30,000 participants at multiple sites across the U.S. and Mexico. Stony Brook is expected to enroll 500 participants, with the vaccine distributed mainly through Stony Brook Medicine’s Advanced Specialty Care in Commack, because of its ease of access and on-site phlebotomy and pharmacy.
Stony Brook was chosen as a trial center, in part, because of the institution’s outstanding expertise in infectious disease research – including vaccinology – and for the ability to perform clinical trials in subjects with complex medical conditions. The study will leverage Stony Brook’s extensive relationships with the first responder and essential worker communities to offer the vaccine trial to those at particularly high risk. Additionally, Stony Brook aims to bring the vaccine trial to underrepresented populations who are also at higher risk for infection.
The clinical trial is a pivotal phase-three study, following phase one and two trials, in which volunteers produced strikingly high levels of antibodies. The results from the phase one study were published in the September issue of The New England Journal of Medicine. There are many benefits to participating in the study:
Level of antibody production. Based on Novavax’s phase two study, patients who received the investigational vaccine have reached protective levels of antibody production lasting for as long as they have been followed in the clinical trial.
Two-to-one randomization. The clinical trial is a two-to-one randomization of an investigational vaccine compared to placebo (most vaccine studies are one to one). This means that for every two people who receive the vaccine candidate, one will receive a placebo — increasing a participant’s chances of receiving the vaccine candidate.
Follow-up and monitoring. Each participant will be monitored for a two-year period. This will allow for a long-term safety assessment of all participants in the clinical trial.
Participants must be enrolled over a six- to eight-week period. They must be over age 18 and have not previously tested positive for COVID-19. At least twenty-five percent of participants must be 65 years of age or older. Those who are more likely to have an increased risk of SARS-CoV-2 infection due to community exposure, such as working in jobs that requires public interaction, are encouraged to participate.
Participants must be in reasonably good health, including those who have preexisting conditions, such as high blood pressure, diabetes or heart disease, that are stable. The investigational vaccine is not live, so participants cannot become ill with COVID-19 as a result of receiving the vaccine candidate. Enrollees are encouraged to have gotten their flu vaccine prior to enrolling in the study. All vaccines, including the flu vaccine, must be received at least four days prior to, or seven days after, receiving any study-related injections.
For more details about the clinical trial and Novavax, see this link.
In response to the growing number of COVID-19 cases on Long Island, Stony Brook University Hospital has reopened its “forward triage” site at the Ambulatory Care Pavilion.
Patients who arrive at the emergency room between 1 p.m. and 9 p.m. are asked to stay in their cars, where a member of the staff will determine the correct emergency care setting. Hospital staff will then direct patients to go to the main Emergency Department or to the coronavirus triage location. The site aims to limit patients with suspected COVID-19 from co-mingling with people coming to the hospital for other medical services.
After seeing nearly 2,600 patients, Stony Brook Medicine closed its “forward triage” site back in May after a decline in patient visits. The site staffed with board-certified emergency medicine physicians and emergency medicine nurses was open from March 9 to May 4.
The state drive-through testing site located in Stony Brook University’s South P Lot off Stony Brook Road remains open. Residents looking to get tested must make appointments in advance by phone at 888-364-3065 or online at www.coronavirus.health.ny.gov/covid-19-testing. Walk-ins are not accepted and will not be seen. The site is open seven days a week. Monday through Friday 8 a.m. to 6 p.m. Saturday and Sunday 8 a.m. to 3 p.m.
When Christopher K. Pendergast was diagnosed with amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s Disease, he was told he had three years to live. He lived 28 years instead. And what a 28 years they were.
Chris Pendergast
Chris, who died on Oct. 14 at age 71, went on to found the ALS Ride for Life in 1997, raising over $10 million for ALS research. The Center for ALS at Stony Brook Medicine now bears his name. And along the way, he met with everyone from U.S. Presidents to legislators to the manager of the New York Yankees. It was all part of his unending quest to help others.
“I want to make a difference,” said the elementary schoolteacher from Miller Place. “I want the extra few years I have to count for something.”
Did he ever.
Chris knew what he was up against. He disdained the term “survivor,” because he knew he would not survive. Instead, he preferred saying that he had lived with ALS for “X” number of years.
On the day he died, his family issued a media statement, saying, “Our dad, despite all odds, lived life just how he wanted until his last morning. He fought ALS bravely for 28 years and dedicated 23 of those years raising awareness and funds for ALS. He touched so many lives but at the end of the day, he was just ‘our dad’ who happened to do remarkable things.”
It wasn’t just by happenstance.
Over the course of 28 years, Chris advocated for patients with ALS, driven to raise funds for ALS research, awareness and patient care through the Ride for Life. He met with other patients with ALS privately and offered them his insights and his friendship for the difficult journey that he knew lay ahead.
Although a quadriplegic, on a ventilator, and using an eye-gaze computer to communicate, Chris remained active with the Ride in his final days.
“Chris taught us much about the range of possibilities of individuals with ALS, about humanity, and the art of what is possible,” said Kenneth Kaushansky, MD, Senior Vice President, Health Sciences, and Dean, Renaissance School of Medicine at Stony Brook University. “His legacy as a trailblazing ALS advocate through the Ride for Life organization and his work at Stony Brook will last for generations to come.”
Based on his work, Chris received the Lifetime Achievement Award from the ALS Association. The ALS Center at Stony Brook Medicine was renamed the Stony Brook Neuromuscular Disease and Christopher Pendergast ALS Center of Excellence in his honor.
“We are proud to have known Chris as a friend, colleague and warrior against ALS,” Dr. Kaushansky said. “We will continue to work to find a cure for ALS, in honor of his life and vision.”
It’s been a rough year for all of us, that’s for sure, but no one has felt the sting of the COVID-19 pandemic more keenly than those who have contracted the virus.
As of Aug. 6, more than 43,000 Suffolk County residents have tested positive for COVID-19, and many more have faced the virus without an official diagnosis. Its symptoms can vary widely, from mild fatigue and chills to flu-like illnesses or even respiratory distress requiring hospital care.
The virus is unpredictable, and dealing with symptoms along with a quarantine, lengthy recovery and uncertain long-term effects is daunting. It’s only natural that many will experience tough emotions along the way.
Stony Brook Medicine is now offering a virtual support group for past and present COVID-19 patients. The weekly sessions will give patients a space to discuss their experiences and feelings while learning healthy coping mechanisms.
The support group is hosted by the Mind-Body Clinical Research Center at the Stony Brook Renaissance School of Medicine. Under the direction of founder Dr. Adam Gonzalez, the center focuses on the integration of mental and physical health for overall wellbeing.
“We wanted to see what we could do to support these members of the community who had COVID-19 and shared that they were feeling anxious, isolated and afraid of transmitting the virus to others,” Gonzalez explained. “Our goal is to provide a telehealth platform for patients to come together and bolster one another, exchange information, and learn skills to cope with stress brought on by their illness.”
Leading the group is Jenna Palladino, a licensed clinical psychologist and clinical assistant professor of psychiatry. Palladino is hopeful that participants will feel comfortable opening up about their struggles with COVID-19 in the company of others who know what it’s like.
“Research supports the idea that sharing your story helps you to work through the emotions related to it. And talking to others experiencing similar feelings helps to normalize the experience,” Palladino said. “It’s important for people going through COVID-19 to know that they’re not alone.”
The initial group is expected to run for 12 weeks, covering topics like coping with isolation, deep breathing, managing anxiety, muscle relaxation and mindfulness, to name a few.
Palladino is also leaving plenty of room for participants to ask questions and discuss topics that interest them, allowing the group to better meet their specific needs and concerns.
Gonzalez added that the support group will act as a pilot program for researchers seeking to understand the experiences of people living with COVID-19. They’ll collect data at the beginning and end of the program to see how patients are doing, if the support group was beneficial and how it can be improved.
While the initial group is limited to 10 patients, Palladino and her team are prepared to quickly begin additional groups if there is an interest, she said.
The virtual COVID-19 support group will be held from 6 to 7 p.m. Thursdays via the free Microsoft Teams video conferencing platform. The group is limited to 10 participants at a time. Registration is required to attend by calling 631-632-8657. For more information and resources, visit www.stonybrookmedicine.edu/COVID19support.
Dr. Kenneth Kaushansky, the dean of the Stony Brook Renaissance School of Medicine at Stony Brook University, is eager to restart the educational mission of training medical school students.
Dr. Kenneth Kaushansky, the dean of the medical school at SBU, said there’s a real possibility of a second wave of COVID-19. File photo
While Gov. Andrew Cuomo (D) has said that medical schools can restart on June 22, Kaushansky has asked for a waiver to allow students to continue to build on their clinical knowledge sooner.
“I was worried about the delay in doing the experiential learning,” Kaushansky said. A delay that lasts too long could push graduation back for the rising fourth year students, which is “not good for any health care professional. We need health care professionals, including respiratory therapists, physical therapists, nurses and social workers” among others.
On top of the need to ensure on-time graduation for the Class of 2021, he said another wave of the COVID-19 crisis will increase the demand for graduates.
The medical school dean said Stony Brook University Hospital is watching carefully the protests over the death of Minneapolis resident George Floyd at the hands of a police officer charged with his murder. The hospital and staff are ready in the event of a spike in demand for health care after large gatherings on Long Island and in New York City.
“We are ready to mobilize on a moment’s notice because we did it the first” time, albeit with numerous questions about the course and potential treatment for the new virus, Kaushansky said.
On Saturday, he sent out a letter to the health sciences community addressing what he termed “health care racism.”
“We witnessed the sum of all these effects in the disproportionate lethal burden of COVID-19 on communities of color, a combination of overcrowding at home, of jobs that do not allow the protection afforded by work from home, or from the disproportionate burden of health care conditions that arise, in part, from health care disparities,” he wrote in the letter. He urged the Stony Brook community to “do everything in our power to work toward erasing the social determinants of disease that contribute to our unequal society.”
He urged learners and critical staff to develop and practice cultural sensitivities, and he also suggested that the school should make “certain our graduates reflect the diverse society in which we live.”
In its admission decisions, SBU includes the notion of overcoming hardship as a part of the process through which the school evaluates prospective students.
In the coming years, Kaushansky plans to emphasize further the importance of encouraging those who have faced significant hurdles in applying to the medical school.
In terms of treating patients who have COVID-19, he is encouraged by the use of remdesivir and convalescent plasma. The school has these treatments available for people who are sick and is studying the effectiveness of these approaches.
More than 1,500 patients have been admitted through the university hospital, Southampton and Eastern Long Island hospitals and have benefited from the clinical study of symptoms including clots.
Surgeons had noticed that D-dimer levels, which are proteins that indicate the presence of clots, were shooting up. They decided when this protein reached a certain level, they would use a full dose of anticoagulants.
Stony Brook has put the results of these aggressive anticoagulant treatments into an article that has been submitted for publication.
In the meantime, the university has taken an across-the-board approach to raising anticoagulants.
“That will improve the mortality rate should we get a second wave,” Kaushansky predicted.
In the event of a second wave, Stony Brook Hospital and, indeed, New York will be better prepared, with more tests, greater awareness and contact tracing.
Kaushansky believes that the people who have already fought off the virus are presumably immune from getting it a second time. What’s unclear, he explained, is whether the antibody test is predictive of resistance. Additionally, it’s unclear how long that resistance will last.
He expects that monoclonal antibodies can work, but that they should be reserved for the sickest patients. They are expensive and are hard to produce the level necessary for the U.S. population of more than 300 million people.
What worries the Stony Brook dean is that people have had enough of staying at home, social distancing and wearing masks. In the worst of the crisis, when the numbers of people sick and dying were climbing, Kaushansky could get to work in much less time than normal, as traffic on the roads had lightened up considerably.
Days before the Phase 2 reopening, which began on Wednesday of this week, the level of traffic has returned to a more normal density.
Meanwhile, Phase 2 for Stony Brook University involves reopening research laboratories and allowing people who were previously deemed nonessential workers to return to the labs in an “orderly and safe fashion,” Kaushansky said.
The university has installed plexiglass shields, requires social distancing, built partitions between people who don’t have their own offices, and requires everyone to wear masks and have their temperatures taken when they come to work.
The hospital opened up for elective surgery two weeks ago. Everyone who is scheduled for surgery has to get a viral swab the day before.
The approach the university has taken in requiring personal protective equipment and social distancing has paid off for hospital staff who have been exposed to all those sick patients. The rate of antibody tests of employees is much lower than in the general community.
“It’s safer to be a frontline health worker at Stony Brook than to work at some grocery stories,” Kaushansky said.
On the clinical side, he believes Stony Brook Hospital needs more highly skilled nurses. At the peak, the university hospital had 437 patients. If it had reached 500, “we would have been in trouble,” he added.
Upstate New York had sent 20 experienced nurses to help out.
“Nursing is important and high-level nursing, operating-room nursing, was particularly stressed,” Kaushansky said. “We need to hire more nurses.”
He added that the school trains excellent nurses and plans to hire some of its own graduates.
In terms of medical school classes, the dean said the university hasn’t decided yet whether to bring small groups back together. The big lecture halls will still involve remote teaching.
“Are the smaller group educational exercises going to be back safely?” he asked. “I’m working to make that happen.”
Kaushansky takes solace in the way PPE reduced the infection rate for the hospital as a whole, and believes such an approach could work for medical school classes as well.
Centerport Resident Among First to Donate Convalescent Blood Plasma
Dr. Elliott Bennett-Guerrero is leading the clinical trial at Stony Brook Medicine which is expected to enroll up to 500 patients who are hospitalized with COVID-19. Photo from Stony Brook Medicine
Stony Brook Medicine has launched a research study in the hopes of developing a treatment for those severely suffering from the coronavirus.
On April 2, SBM began a U.S. Food and Drug Administration-approved research study to determine if convalescent blood plasma from those who’ve recovered from COVID-19 can help treat currently hospitalized patients. One of the first volunteers was Mark Goidell, a litigation attorney from Centerport.
COVID-19 survivor Mark Goidell donates blood plasma for a research study at SBU. Photo from Stony Brook Medicine
The Research Study
Dr. Elliott Bennett-Guerrero, vice chair of Clinical Research and Innovation in the Renaissance School of Medicine Department of Anesthesiology, is heading up the research study. He said the hospital needs approximately 100 volunteers who have recovered from the coronavirus to donate blood plasma, possibly once a week or every other week. Subjects must have contracted COVID-19 and be free of symptoms for 14 days. As of April 22, the doctor said they have received a large number of inquiries leading to 180 people being screened and 90 have been identified as having high levels of antibodies. Currently 25 have either donated blood plasma or are scheduled to do so.
Bennett-Guerrero said researchers are looking for those with high antibody levels of the virus and testing takes about 15 minutes. The donors must also meet regular criteria to be a blood donor, the doctor said, which includes being at least 17 years old, weighing more than 100 pounds, and having no infections Certain travel outside of the U.S. will also be reviewed.
“We’re very fortunate that we can run this protocol independently, because we have access to a very good test for antibodies, and we also have a licensed blood collection facility already in our hospital,” the doctor said. “So we have those two main ingredients to help us to collect blood plasma and unfortunately have a large number of patients who are in desperate need of help.”
Bennett-Guerrero said the trial will include 500 hospital patients ranging from those who are intubated and those who are not. A higher percentage of patients will receive convalescent serum on a random basis compared to other trials which tend to have 50 percent of patients serve as a control group who receive a placebo.
“Our protocol is unique in that while we want to help as many people as possible, we also want to determine if it’s safe and effective,” the doctor said. “It’s a randomized trial where 80 percent of the patients will receive the convalescent plasma because we hope to benefit as many patients as possible, and there will be a small group of 20 percent of patients that will serve as the control group and get standard plasma. It’s the only way we can rigorously determine if it’s safe and effective to do this.”
Plasma, which is the liquid portion of the blood, helps with clotting and supporting immunity. The hope is the plasma from those who have survived COVID-19 will contain antibodies which in turn can kill the virus in seriously ill patients. According to SBM, convalescent serum therapy is a century-old treatment that has been used in patients during the Spanish Flu pandemic of 1918, the diphtheria epidemic in the U.S. in the 1920s, and more recently, the Ebola outbreak in 2014.
The doctor said it’s too early to determine if giving convalescent blood plasma to a COVID-19 patient will help.
“It’s very early in the stage with this pandemic,” he said. “We’re only beginning to learn what are the patterns of antibody formation in people who had the COVID-19 infection. In general it’s believed that antibodies to COVID-19 will probably persist for a while, perhaps months or years, and likely be protective. However, we don’t know yet if the antibodies that we are measuring actually mean, ‘quote-unquote,’ one is immune and can’t be reinfected. We think that’s probably the case but it’s not proven yet.”
Blood plasma donor Mark Goidell and his wife, Lynn, recently recovered from the coronavirus. Photos from Stony Brook Medicine
The Donor
The doctor said Goidell was a good candidate because he was free of symptoms for a couple of weeks, had high levels of the antibodies in his system and met blood donation criteria.
Both Goidell, 64, and his wife Lynn, 62, came down with the virus. The attorney said he was sick toward the end of February and in early March, and his symptoms included being lethargic and feverish, and at times during the night he would frequently wake up and try to catch his breath, many times going outside to do so.
His wife was admitted to Huntington Hospital March 13 due to having double pneumonia and was discharged a few days later. Goidell said he did have a relapse where he said his symptoms felt like a sinus infection, with a loss of smell and taste. He said he has recovered about 70 percent of those senses.
While his symptoms didn’t initially lead to testing, he said, once his wife was hospitalized he was tested March 17 at an urgent care facility. After reading about the Stony Brook study on the News12 website, Goidell said he was more than willing to participate in the trial.
“It’s heartbreaking to see what’s happening and all the tragedy and anguish that is being brought about by the virus,” Goidell said. “I’m grateful for the fact that I’ve recovered, and I’m able to do something to help.”
He said he feels fortunate to live in close proximity to Stony Brook Medicine. Between his experience with the study so far and his wife’s hospital stay at Huntington Hospital, he has gained an even greater respect and admiration for health care workers. He called those who treated his wife “heroes.”
He added the two of them are now back to working remotely, joking that he has put on some weight due to his wife’s good cooking, and he has been playing a lot of basketball in his driveway to burn off the pounds.
He said he hopes that others who have recovered will donate their plasma, and that others will “stay inside and help each other out.”
“I wish Dr. Bennett-Guerrero and the researchers at Stony Brook the best of luck, and I have the most gratitude for the work they are doing,” he said.
People who have recovered from COVID-19 and want to donate blood plasma can visit www.stonybrookmedicine.edu/COVID_donateplasma where they will be required to fill out an online survey. Potentially eligible people will be asked to participate in a screening visit at a Stony Brook Medicine facility, which will take approximately 30 minutes. You do not need to be a Stony Brook University Hospital patient to participate, but you must meet the required criteria for plasma donation and have high levels of antibodies to the virus that causes COVID-19.
Stony Brook Medicine has taken further precautions due to the coronavirus pandemic, according to its website.
Stony Brook University is asking that all patients who have cold and flu-like symptoms go directly to its emergency room department. Between 11 a.m. and 11 p.m., patients driving to the emergency department entrance will be greeted and screened while in their vehicles.
Those with cold and flu-like symptoms and mild respiratory symptoms will be directed by staff members to go to the hospital’s new triage area located in the nearby Ambulatory Care Pavilion. The triage area will be staffed by emergency medicine physicians and nurses.
According to Stony Brook Medicine, “the triage service is to separate patients with cold and flu-like symptoms from others seeking emergent care, in order to provide all patients with a streamlined environment for care and treatment.”
SBUH has also revised its visitors policy. In response to New York State declaring a State of the Emergency due to COVID-19, the hospital will no longer allow visitation until further notice.
Prev
